A subsidiary of Asence Inc., a New York-based pharmaceutical company and part of the Sarabhai Group, specializing in supplying quality pharmaceutical APIs, finished dosage formulations and effervescent products to international markets. Asence Pharma recently received a Certificate of Suitability (CEP 2024-118) for Amphotericin B (Parenteral Grade), manufactured at Synbiotics Limited, India — marking India's first CEP for parenteral-grade Amphotericin B.

No hay comentarios disponibles.
Deja tu valoración & comentario